A highly advanced omega-3 ingredient, MaGOmega® is manufactured using innovative enzymatic transesterification technology in our specialized facility in Mallén, Zaragoza, Spain.
Sourced from algae – one of our planet’s most sustainable and renewable sources of omega-3 – MaGOmega® is a patented*, vegan Monoglyceride (MAG) form, with Solutex holding all patent rights.
* Patented in USA (US8,119,690; US8,198,324); Canada (CA2672513; CA2677670); Australia (AU2008215077); and Europe (EP2121576B1).
Small but mightyAll the benefits of omega-3 in a lower dosage
The unique composition of MaGOmega® promotes bioavailability, allowing it to auto-emulsify and facilitate the absorption of EPA and DHA, the essential fatty acids that are critical for human health.
It is designed to take advantage of the natural lipid absorption capacity of the human body, which favors monoglycerides and free fatty acids, creating favorable enzymatic conditions in the intestine. This enhances the absorption of EPA and DHA, when compared to triglycerides (TG), and ethyl esters (EE).
MaGOmega® is manufactured at our state-of-the-art facility in Europe from the Schizochytrium species of micro-algae:
Fermentation in North America & Europe, concentration in Spain